Our data distinctly indicate that IL-35 expression is substantially up-regulated in EGFR-mutant NSCLC rather than EGFR wild-type tumors, highlighting IL-35 as a potential mediator of EGFR mutation-associated immunosuppression. Here, EGFR is linked to non-small cell lung carcinoma.